Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: @pappythom

"...where does RG state there are no future licensees in sight"

Yes, your're right he didn't state it, but I expected an outlook of what's happening to our BIGGEST (and IMO only significant) source of revenue.

Fact is there are no more new licensees since a long time (we don't know what's behind the Asutek deal) and as long as they can't give us and potential investors any clues about the MMP, there will be NO NEW INVESTORS. I don't expect people to invest in PTSC because of the Crossflo business (as it is today). Only if this business gets huge with additional M&As, this could get interesting.

And remember: for our last CEOs it was no problem to speak about the potential of the MMP - and now?

So if RG would expect new licensees e.g. because of the german validation, couldn't he say something like: "I'm expecting a new/higher interest to become a MMP-licensee in the next months" - but by not saying something like this, I have to conclude, there is nothing to come in the nearer future.

GLTY





Share
New Message
Please login to post a reply